Location History:
- Montpellier, FR (2013)
- Narbonne, FR (2014)
Company Filing History:
2 out of 5,081 
1 out of 154 
1 out of 1 
Years Active: 2013-2014
Title: The Innovative Contributions of David Brevet
Introduction
David Brevet is a notable inventor based in Narbonne, France. He has made significant contributions to the field of photodynamic therapy through his innovative inventions. With a total of 2 patents, Brevet's work focuses on advanced compounds and nanoparticles that have the potential to revolutionize cancer treatment.
Latest Patents
David Brevet's latest patents include groundbreaking inventions such as biphotonic photosensitizers and nanoparticles containing the same, which are utilized as drugs. His inventions relate to compounds of formula (I) and metalloporphyrin derivatives. These nanoparticles enable the simultaneous targeting, imaging, and treatment of cancerous cells using photodynamic therapy. Additionally, he has developed novel molecules derived from porphyrins and silica-based nanoparticles, which are also aimed at enhancing photodynamic therapy.
Career Highlights
Throughout his career, David Brevet has worked with prestigious organizations, including the Centre National de la Recherche Scientifique and Institut Curie. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical technology.
Collaborations
Some of his notable coworkers include Jean-Olivier Durand and Alain Morere. Their collaborative efforts have further enriched the research and development of innovative therapies in the medical field.
Conclusion
David Brevet's contributions to the field of photodynamic therapy through his patents and collaborations highlight his role as a key innovator in cancer treatment. His work continues to inspire advancements in medical technology and offers hope for improved therapeutic options.